Clinical Trials Logo

Clinical Trial Summary

It has previously been reported that men with prostate cancer are 1 ) reduced quality of life after diagnosis and treatment, 2 ) neuroticism increases the reduction in QoL related to treatment side effects, and 3) often have very involved and active spouses who seems to have been handed over / taken over parts of the men's responsibility for their own health. We postulate herein a new hypothesis that the stress level is elevated when harbouring undetected prostate cancer. We will investigate whether those who are diagnosed with prostate cancer already in beforehand have an increased degree of masculine stress ( experience of not living up to their own perception of the ideal man ) and neuroticism in the typology. We will examine different personality and QoL questionnaires for patients with elevated PSA, and compare those whose clinical assessment later reveals prostate cancer, with three control groups: 1) men with elevated PSA who are not diagnosed with prostate cancer, 2) men with normal PSA treated for benign prostate enlargement and 3) patient with substantial risk of colorectal cancer (CRC) who undergo colonoscopy, with regard to increased level of masculine stress and the personality trait neuroticism.


Clinical Trial Description

Inclusion criteria:

1. Men who are being referred as new urological outpatient and meet the following criteria:

1. Wanted clinical examined because of elevated PSA

2. Not strong family history of prostate cancer

3. It is taken biopsy as part of routine investigation.

2. Control groups: Men being referred to urological / gastroenterological outpatient clinic, and which meet the following criteria:

1. urination complaints, normal PSA, and study shows prostate size> 40cc

2. Or melena and cancer suspicion in colorectum

3. Age> 18 years and <75 years

Outcome measures:

Together with statistician look for patterns / covariance in replies from those who are diagnosed with prostate cancer in the questionnaires personality evaluation adapted to normal population (Neo-FFI), gender differentiated stress response questionnaire (MGRSS) and questionnaires related to resilience, relationship and quality of life index, compared with the control groups. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02031029
Study type Observational [Patient Registry]
Source Helse Stavanger HF
Contact
Status Terminated
Phase N/A
Start date December 2013
Completion date December 18, 2015

See also
  Status Clinical Trial Phase
Completed NCT00941343 - Benign Prostatic Hyperplasia in Taiwan N/A
Completed NCT00575913 - Alfuzosin XL Lower Urinary Tract Symptoms Efficacy and Sexuality Study Phase 4
Completed NCT02074644 - Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia N/A
Active, not recruiting NCT03344757 - Health Gatherings - For Your Health After Cancer N/A
Terminated NCT02606123 - Safety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate Cancer Phase 1/Phase 2
Not yet recruiting NCT02245334 - A Prospective Trial of Povidone-iodine Suppository Before Transrectal Ultrasound Guided Prostate Biopsy Phase 4
Active, not recruiting NCT01464216 - MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness
Not yet recruiting NCT05574647 - Imperial Prostate 7 - Prostate Assessment Using Comparative Interventions - Fast Mri and Image-fusion for Cancer N/A
Completed NCT03192917 - Low-energy Extracorporeal Shockwave Treatment for Patients After Radical Prostatectomy N/A
Recruiting NCT03711643 - Hypnosis Mask: a New Approach to Management of Pain in Medical Imaging N/A
Completed NCT03104907 - Prostatic Artery Embolization for Obstructive Uropathy Due to Prostate Cancer N/A
Completed NCT03099421 - Prostatic Artery Embolization for Benign Prostatic Obstruction N/A
Completed NCT00853710 - Test Semiquantitative Prostate Specific Antigen (PSA) N/A
Completed NCT01316458 - Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy Phase 2
Recruiting NCT05413850 - Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection Phase 1/Phase 2
Completed NCT05941260 - Standardization of Prostatic Resection by Virtual Computational Reconstruction and Computational Flow Dynamics
Completed NCT00484783 - Transluminal Flexible Endoscopic Procedure in Foregut and Urologic Surgery N/A
Terminated NCT00672009 - A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer Phase 2
Approved for marketing NCT04452136 - Expanded Access Protocol of 68Ga PSMA 11 PET Imaging of Prostate Cancer